BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 29508242)

  • 1. Dynamic susceptibility contrast (DSC) perfusion MRI in differential diagnosis between radionecrosis and neoangiogenesis in cerebral metastases using rCBV, rCBF and K2.
    Muto M; Frauenfelder G; Senese R; Zeccolini F; Schena E; Giurazza F; Jäger HR
    Radiol Med; 2018 Jul; 123(7):545-552. PubMed ID: 29508242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging.
    Xu Q; Liu Q; Ge H; Ge X; Wu J; Qu J; Xu K
    Medicine (Baltimore); 2017 Dec; 96(50):e9332. PubMed ID: 29390403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
    Thomsen H; Steffensen E; Larsson EM
    Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DCE and DSC perfusion MRI diagnostic accuracy in the follow-up of primary and metastatic intra-axial brain tumors treated by radiosurgery with cyberknife.
    Morabito R; Alafaci C; Pergolizzi S; Pontoriero A; Iati' G; Bonanno L; Gaeta M; Salpietro FM; Mormina E; Longo M; Granata F
    Radiat Oncol; 2019 Apr; 14(1):65. PubMed ID: 30992043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging-based tumour perfusion parameters are biomarkers predicting response after radiation to brain metastases.
    Jakubovic R; Sahgal A; Soliman H; Milwid R; Zhang L; Eilaghi A; Aviv RI
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):704-12. PubMed ID: 25023291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of Magnetic Resonance Perfusion Imaging in Quantifying Active Tumor Fraction and Radiation Necrosis in Recurrent Intracranial Tumors.
    Shah AH; Kuchakulla M; Ibrahim GM; Dadheech E; Komotar RJ; Gultekin SH; Ivan ME
    World Neurosurg; 2019 Jan; 121():e836-e842. PubMed ID: 30312826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absolute CBV for the differentiation of recurrence and radionecrosis of brain metastases after gamma knife radiotherapy: a comparison with relative CBV.
    Wang B; Zhao B; Zhang Y; Ge M; Zhao P; Na Sun ; Li C; Pang Q; Xu S; Liu Y
    Clin Radiol; 2018 Aug; 73(8):758.e1-758.e7. PubMed ID: 29764622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method.
    Cebeci H; Aydin O; Ozturk-Isik E; Gumus C; Inecikli F; Bekar A; Kocaeli H; Hakyemez B
    Eur J Radiol; 2014 Oct; 83(10):1914-9. PubMed ID: 25087109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic contrast-enhanced susceptibility-weighted perfusion imaging of intracranial tumors: a study using a 3T MR scanner.
    Sentürk S; Oğuz KK; Cila A
    Diagn Interv Radiol; 2009 Mar; 15(1):3-12. PubMed ID: 19263367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis.
    Server A; Orheim TE; Graff BA; Josefsen R; Kumar T; Nakstad PH
    Neuroradiology; 2011 May; 53(5):319-30. PubMed ID: 20625709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Diffusion Tensor Imaging and Magnetic Resonance Perfusion Imaging in Differentiating Recurrent Brain Neoplasm From Radiation Necrosis.
    Masch WR; Wang PI; Chenevert TL; Junck L; Tsien C; Heth JA; Sundgren PC
    Acad Radiol; 2016 May; 23(5):569-76. PubMed ID: 26916251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of dynamic susceptibility-contrast MRI (DSC-MRI) to assess perfusion changes in the ipsilateral brain parenchyma from glioblastoma.
    Ulmer S; Liess C; Kesari S; Otto N; Straube T; Jansen O
    J Neurooncol; 2009 Jan; 91(2):213-20. PubMed ID: 18807224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-Enhanced Perfusion MR Imaging to Differentiate Between Recurrent/Residual Brain Neoplasms and Radiation Necrosis.
    Metaweh NAK; Azab AO; El Basmy AAH; Mashhour KN; El Mahdy WM
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):941-948. PubMed ID: 29693348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of relative permeability and relative cerebral blood volume in high-grade cerebral neoplasms.
    Provenzale JM; York G; Moya MG; Parks L; Choma M; Kealey S; Cole P; Serajuddin H
    AJR Am J Roentgenol; 2006 Oct; 187(4):1036-42. PubMed ID: 16985154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misleading early blood volume changes obtained using ferumoxytol-based magnetic resonance imaging perfusion in high grade glial neoplasms treated with bevacizumab.
    Netto JP; Schwartz D; Varallyay C; Fu R; Hamilton B; Neuwelt EA
    Fluids Barriers CNS; 2016 Dec; 13(1):23. PubMed ID: 27998280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery.
    Cicone F; Minniti G; Romano A; Papa A; Scaringi C; Tavanti F; Bozzao A; Maurizi Enrici R; Scopinaro F
    Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):103-11. PubMed ID: 25182751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective comparative diagnostic accuracy evaluation of dynamic contrast-enhanced (DCE) vs. dynamic susceptibility contrast (DSC) MR perfusion in differentiating tumor recurrence from radiation necrosis in treated high-grade gliomas.
    Zakhari N; Taccone MS; Torres CH; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Cron GO; Thornhill RE; McInnes MDF; Nguyen TB
    J Magn Reson Imaging; 2019 Aug; 50(2):573-582. PubMed ID: 30614146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differentiation between glioma recurrence and radiation-induced brain injuries using perfusion-weighted magnetic resonance imaging].
    Wang YL; Liu MY; Wang Y; Xiao HF; Sun L; Zhang J; Ma L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):416-21. PubMed ID: 23987489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
    Law M; Young R; Babb J; Rad M; Sasaki T; Zagzag D; Johnson G
    AJNR Am J Neuroradiol; 2006 Oct; 27(9):1975-82. PubMed ID: 17032878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfusion Computed Tomography (PCT) adopting different perfusion metrics: recurrence of brain metastasis or radiation necrosis?
    Vidiri A; Guerrisi A; Pinzi V; Fabi A; Mirri MA; Pompili A; Caporale N; Pace A; Crecco M; Marzi S
    Eur J Radiol; 2012 Jun; 81(6):1246-52. PubMed ID: 21458183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.